Robert T Lawrence (Robert Lawrence)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

High Performance Liquid Chromatography

Insulin Resistance

Top Venues

Nature communications

Molecular cancer therapeutics

University of Washington (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Washington

United States

PHD :: Molecular and Cellular Biology

Publications

Rebecca Mazahreh, Marsha L Mason, John J Gosink, Devra J Olson, Robert Thurman, Christopher J Hale, Lori Westendorf, Thomas A Pires, Christopher I Leiske, Markus Carlson, Liem T Nguyen, Julia H Cochran, Nicole M Okeley, Roma Yumul, Steven Jin, Ivan J Stone, Disha Sahetya, Albina Nesterova, Sean Allred, Kelly M Hensley, Rachael Hu, Robert T Lawrence, Timothy S Lewis, Sharsti Sandall
SGN-CD228A is an investigational CD228-directed antibody-drug conjugate with potent antitumor activity across a wide spectrum of preclinical solid tumor models. Molecular cancer therapeutics (2023)
Stephanie J Alexopoulos, Sing-Young Chen, Amanda E Brandon, Joseph M Salamoun, Frances L Byrne, Christopher J Garcia, Martina Beretta, Ellen M Olzomer, Divya P Shah, Ashleigh M Philp, Stefan R Hargett, Robert T Lawrence, Brendan J Lee, James Sligar, Pascal Carrive, Simon P Tucker, Andrew Philp, Carolin Lackner, Nigel Turner, Gregory J Cooney, Webster L Santos, Kyle Lee Hoehn
Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice. Nature communications 11 (1) (2020)
Brian C Searle, Robert T Lawrence, Michael J MacCoss, Judit Vill N
Thesaurus: quantifying phosphopeptide positional isomers. Nature methods 16 (8) (2019)